Profile
Full Name
Immuneering CorporationTicker Symbol
IMRXExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
July 30, 2021Indexes
Not includedWebsite
http://immuneering.comEmployees
66Key Details
Price
$1.27(+1.60%)
Market cap
$45.58M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
-
Annual EPS
-$2.04(-8.51% YoY)
PE ratio
-
Next earnings date
May 7, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Immuneering doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Apr 10, 25 Needham
BuyMar 24, 25 Chardan Capital
BuyMar 21, 25 Needham
BuyFeb 6, 25 Needham
BuyJan 13, 25 Needham
BuyJan 8, 25 Chardan Capital
BuyJan 7, 25 Needham
BuyNov 20, 24 Chardan Capital
BuyNov 14, 24 Needham
BuySep 13, 24 Needham
BuyInstitutional Ownership
- What is the ticker symbol for Immuneering?
- Does Immuneering pay dividends?
- What sector is Immuneering in?
- What industry is Immuneering in?
- What country is Immuneering based in?
- When did Immuneering go public?
- Is Immuneering in the S&P 500?
- Is Immuneering in the NASDAQ 100?
- Is Immuneering in the Dow Jones?
- When was Immuneering's last earnings report?
- When does Immuneering report earnings?
- Should I buy Immuneering stock now?
What is the ticker symbol for Immuneering?
The ticker symbol for Immuneering is NASDAQ:IMRX
Does Immuneering pay dividends?
No, Immuneering does not pay dividends
What sector is Immuneering in?
Immuneering is in the Healthcare sector
What industry is Immuneering in?
Immuneering is in the Biotechnology industry
What country is Immuneering based in?
Immuneering is headquartered in United States
When did Immuneering go public?
Immuneering's initial public offering (IPO) was on July 30, 2021
Is Immuneering in the S&P 500?
No, Immuneering is not included in the S&P 500 index
Is Immuneering in the NASDAQ 100?
No, Immuneering is not included in the NASDAQ 100 index
Is Immuneering in the Dow Jones?
No, Immuneering is not included in the Dow Jones index
When was Immuneering's last earnings report?
Immuneering's most recent earnings report was on Mar 20, 2025
When does Immuneering report earnings?
The next expected earnings date for Immuneering is May 7, 2025
Should I buy Immuneering stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions